Fürst et al., 1993 - Google Patents
Are We Giving Unbalanced Amino Acid Solutions? -From Protein Hydrolysates to Tailored SolutionsFürst et al., 1993
- Document ID
- 15095442762805823147
- Author
- Fürst P
- Stehle P
- Publication year
- Publication venue
- Metabolic support of the critically ill patient
External Links
Snippet
It has been known for more than 50 years that a severe traumatic injury gives rise to striking changes in metabolism. In particular, there is a marked increase in nitrogen (N) excretion indicating net protein catabolism and an enhanced oxygen utilization, demonstrating …
- 150000001413 amino acids 0 title abstract description 90
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
- A61K47/16—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Quaternary ammonium compounds, e.g. amides, ureas
- A61K47/183—Amino acids or aminosulphonic acids, e.g. glycine, EDTA, aspartame
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5576287A (en) | Method for treating acute renal disease and failure | |
| US5719119A (en) | Parenteral nutrition therapy with amino acids | |
| JP6771191B2 (en) | Carboxylic acid mixture for the treatment of patients with renal failure | |
| USRE35233E (en) | Method of treating catabolic dysfunction | |
| Ziegler et al. | Potential role of glutamine supplementation in nutrition support | |
| US5462924A (en) | Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa | |
| MX2008013540A (en) | Paediatric amino acid solution for parenteral nutrition. | |
| WO1987003806A1 (en) | Parenteral nutrition therapy with amino acids | |
| CA1285491C (en) | Method of treating catabolic dysfunction | |
| OKITA et al. | Nutritional treatment of liver cirrhosis by branched-chain amino acid-enriched nutrient mixture | |
| Wernerman et al. | Glutamine: a necessary nutrient for the intensive care patient | |
| Dudrick et al. | Amino acids in surgical nutrition: Principles and practice | |
| Lambert et al. | Net portal absorption of enterally fed α-ketoglutarate is limited in young pigs | |
| US6797729B1 (en) | Therapeutic glutamine and N-actyl-cysteine composition | |
| Motil et al. | Complications of essential amino acid hyperalimentation in children with acute renal failure | |
| JPH08175987A (en) | Oral and enteral nutritive composition | |
| CA2134380C (en) | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man | |
| Fürst et al. | Are We Giving Unbalanced Amino Acid Solutions? -From Protein Hydrolysates to Tailored Solutions | |
| Welbourne et al. | Enteral glutamine supports hepatic glutathione efflux during inflammation | |
| Breuille et al. | Cysteine and glutathione in catabolic states | |
| Filip et al. | The role of glutamine and alfa-ketoglutarate in gut metabolism and the potential application in medicine and nutrition | |
| Leguina-Ruzzi et al. | Glutamine: a conditionally essential amino acid with multiple biological functions | |
| JP3914585B2 (en) | Macrophage nitric oxide production enhancer | |
| Neuhäuser-Berthold | Amino Acid Derivates as a Source of Amino Acids in Parenteral Nutrition | |
| Jonas et al. | Potential role of glutamine administration in inflammatory bowel disease |